7 research outputs found

    Bruno Nardi's Louvain Dissertation (1911) and tne Uneasy Character of Dante's Philosophy

    No full text
    L'articolo ricostruisce le principali linee interpretative della tesi lovaniense di Bruno Nardi (1911), intitolata "Sigieri di Brabante nella Divina Commedia e le fonti della filosofia di Dante"

    Frequency of EMVI in relation to site of primary tumour.

    No full text
    <p>(A) All cases. (B) Cases that had not received neoadjuvant therapy. (C) Cases that had received neoadjuvant therapy. (D) Non-screen-detected cases. (E) Bowel cancer screening detected cases.</p

    Relationship between extramural venous invasion and survival in Dukes’ B cancers.

    No full text
    <p>(A) All patients (n = 372). (B) Patients who did not receive neoadjuvant therapy (n = 301). (C) Patients who received neoadjuvant therapy (n = 71).</p

    Frequency of EMVI reporting per Dukes’ stage of primary tumour.

    No full text
    <p>(A) All cases. (B) Cases that had not received neoadjuvant therapy. (C) Cases that had received neoadjuvant therapy. (D) Non-screen-detected cases. (E) Bowel cancer screening detected cases.</p

    Frequency of EMVI reporting per tumour (T) stage of primary tumour.

    No full text
    <p>(A) All cases. (B) Cases that had not received neoadjuvant therapy. (C) Cases that had received neoadjuvant therapy. (D) Non-screen-detected cases. (E) Bowel cancer screening detected cases. T0 represents cases in which there was a complete pathological response of the primary tumour to neoadjuvant therapy.</p

    Relationship between extramural venous invasion and survival in Dukes’ C cancers.

    No full text
    <p>(A) All patients (n = 390). (B) Patients who did not receive neoadjuvant therapy (n = 319). (C) Patients who received neoadjuvant therapy (n = 71).</p

    Frequency of EMVI reporting per lymph node (N) stage of primary tumour.

    No full text
    <p>(A) All cases. (B) Cases that had not received neoadjuvant therapy. (C) Cases that had received neoadjuvant therapy. (D) Non-screen-detected cases. (E) Bowel cancer screening detected cases.</p
    corecore